149 related articles for article (PubMed ID: 28498834)
21. Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.
Xu L; Peng H; Huang XX; Xia YB; Hu KF; Zhang ZM
Braz J Med Biol Res; 2018 Jul; 51(9):e7588. PubMed ID: 30043858
[TBL] [Abstract][Full Text] [Related]
22. RAD18 promotes colorectal cancer metastasis by activating the epithelial‑mesenchymal transition pathway.
Li P; He C; Gao A; Yan X; Xia X; Zhou J; Wu J
Oncol Rep; 2020 Jul; 44(1):213-223. PubMed ID: 32319669
[TBL] [Abstract][Full Text] [Related]
23. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
Liu Y; Zhang M; Liang L; Li J; Chen YX
Int J Clin Exp Pathol; 2015; 8(9):11480-4. PubMed ID: 26617879
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.
Zhou K; Liang H; Liu Y; Yang C; Liu P; Jiang X
Tumour Biol; 2013 Dec; 34(6):3691-9. PubMed ID: 23852859
[TBL] [Abstract][Full Text] [Related]
25. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
[TBL] [Abstract][Full Text] [Related]
26. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
[TBL] [Abstract][Full Text] [Related]
27. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis.
Chen H; Peng H; Liu W; Sun Y; Su N; Tang W; Zhang X; Wang J; Cui L; Hu P; Liu S
Surgery; 2015 Dec; 158(6):1704-13. PubMed ID: 26275833
[TBL] [Abstract][Full Text] [Related]
28. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
29. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
[TBL] [Abstract][Full Text] [Related]
30. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
31. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study.
Wang Y; Yang W; Liu T; Bai G; Liu M; Wang W
Medicine (Baltimore); 2019 Jul; 98(27):e16237. PubMed ID: 31277140
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
34. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
Yu L; Lu Y; Han X; Zhao W; Li J; Mao J; Wang B; Shen J; Fan S; Wang L; Wang M; Li L; Tang J; Song B
Stem Cell Res Ther; 2016 Dec; 7(1):180. PubMed ID: 27906093
[TBL] [Abstract][Full Text] [Related]
35. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
Wang D; Xu MR; Wang T; Li T; Zhu Jw
J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
[TBL] [Abstract][Full Text] [Related]
36. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
[TBL] [Abstract][Full Text] [Related]
37. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
[TBL] [Abstract][Full Text] [Related]
38. [Expression and clinical significance of GRHL2 in colorectal cancer].
Quan Y; Xu M; Cui P; Ye M; Zhuang B; Min Z
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):764-8. PubMed ID: 26813596
[TBL] [Abstract][Full Text] [Related]
39. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
